Washington Biomedical Research Properties I is categorized under Real Estate in Seattle, WA and active since 2002.
Washington Biomedical Research Properties I was established in 2002, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Real Estate business, which does work in the BOTH market, and is classified as a Real Estate, under code number 531210 by the NAICS.
If you are seeking more information, feel free to contact Robert Davenport at the company’s single location by writing to 1218 3rd Avenue # 1403, Seattle, Washington WA 98101 or by phoning (206) 448-5244. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Washington Biomedical Research Properties I |
| Contact Person: | Robert Davenport |
| Address: | 1218 3rd Avenue # 1403, Seattle, Washington 98101 |
| Phone Number: | (206) 448-5244 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2002 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B & B2C |
| Business Category: | Real Estate |
| SIC Code: | 6531 |
| NAICS Code: | 531210 |
| Share This Business: |
Washington Biomedical Research Properties I was started in 2002 to provide professional Real Estate under the SIC code 6531 and NAICS code 531210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Robert Davenport for inquiries that concern Washington Biomedical Research Properties I by calling the company number (206) 448-5244, as your correspondence is most welcome. Additionally, the physical location of the single location of Washington Biomedical Research Properties I can be found at the coordinates 47.607288,-122.335323 as well as the street address 1218 3rd Avenue # 1403 in Seattle, Washington 98101.
For its online presence, you may visit Washington Biomedical Research Properties I’s website at and engage with its social media outlets through on Twitter and on Facebook.